Abeona therapeutics to participate in the cantor fitzgerald virtual rare orphan disease summit

New york and cleveland, march 28, 2022 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that vish seshadri, ph.d., chief executive officer of abeona therapeutics, will participate in a panel discussion titled, “cell therapy: how the definition has expanded with time, and the potential applications for rare diseases,” at the cantor fitzgerald virtual rare disease summit on wednesday, march 30, 2022 at 4:00 p.m. et.
ABEO Ratings Summary
ABEO Quant Ranking